Insider Trading March 20, 2026

Major Share Purchases by 10% Holder Follow Neuronetics’ Mixed Quarterly Results

Insider Jorey Chernett spends $1.42 million acquiring additional Neuronetics shares amid recent earnings and valuation shifts

By Avery Klein STIM
Major Share Purchases by 10% Holder Follow Neuronetics’ Mixed Quarterly Results
STIM

Jorey Chernett, identified as a roughly 10% owner of Neuronetics, Inc. (NASDAQ: STIM), completed stock purchases totaling $1.42 million across filings dated March 18 and March 19, 2026. The transactions increased Chernett's direct stake to 8,573,804 shares. The purchases coincided with a recent one-week share price gain and follow the company’s fourth-quarter 2025 results, which showed revenue above expectations but an EPS shortfall. Independent valuation data cited in filings places the stock above its stated Fair Value.

Key Points

  • Insider purchases: Jorey Chernett, a ten percent owner, bought $1.42 million in Neuronetics stock across March 18-19, 2026, raising direct ownership to 8,573,804 shares.
  • Recent financials: Neuronetics reported Q4 2025 revenue of $41.8 million (2.73% above forecast) but missed EPS expectations at -$0.10 versus an anticipated -$0.09.
  • Valuation and market context: The stock traded at $1.51 and gained about 17% over the prior week; InvestingPro data cited a market cap of $104.95 million and indicates the share price exceeds a Fair Value of $1.22 while the stock is down 69% over the past year.

Insider buying activity at Neuronetics, Inc. (NASDAQ: STIM) was disclosed in recent Securities and Exchange Commission filings that show Jorey Chernett, identified as a ten percent owner, purchased a total of $1.42 million in common stock across two days of transactions.

The Form 4 filing details that on March 18, 2026, Chernett acquired 607,400 shares in multiple trades priced between $1.33 and $1.37, with a reported weighted average price of $1.35. A subsequent series of purchases on March 19, 2026, added 450,000 shares at prices ranging from $1.29 to $1.48 and a weighted average price of $1.33. After these purchases Chernett is recorded as directly owning 8,573,804 Neuronetics shares.

Market data included in the disclosure notes that the company was trading at $1.51 at the time the report was compiled, a level that reflected a roughly 17% gain over the previous week following the transactions. Additional valuation context in the filing cites InvestingPro data indicating a market capitalization of $104.95 million. The same source asserts that the stock is down 69% over the last year and is trading above a stated Fair Value of $1.22.


Earnings and analyst moves

The filings and public disclosures referenced in the submission to regulators also recap Neuronetics’ fourth-quarter 2025 financial results. The company reported revenue of $41.8 million, exceeding the consensus forecast of $40.66 million and representing a 2.73% positive surprise versus estimates. Earnings per share were reported at -$0.10, however, missing the expected -$0.09 and constituting an 11.11% negative surprise.

On the analyst front, Canaccord cut its price target on Neuronetics from $7.00 to $3.00 but retained a Buy rating. The firm’s adjustment is characterized in the filings as a response to a valuation reset even as Neuronetics posted an operationally cash flow positive second quarter. The company also disclosed a leadership change, naming Dan Reuvers as its new chief executive officer.


What the filing says about further research

Investors seeking expanded analysis are directed in the filing to a Pro Research Report available on InvestingPro for additional detail on valuation and financial metrics. The filing itself provides the concrete transaction figures, ownership totals and the market and valuation context summarized above.

The SEC Form 4 entries provide precise trade-level information: the March 18 block of 607,400 shares (weighted average $1.35) and the March 19 block of 450,000 shares (weighted average $1.33), with the combined disclosed outlay equal to $1.42 million. Beyond the transaction arithmetic, the filings reiterate the company’s recent operating results, the analyst price-target revision, and the executive succession.

Risks

  • Share-price volatility - The stock has fallen 69% over the past year and recently showed a material weekly gain, illustrating sharp price moves that may affect investor timing and market sentiment.
  • Earnings shortfall - The fourth-quarter 2025 EPS missed expectations, pointing to potential near-term profitability challenges that could influence analyst outlooks and capital markets reception.
  • Valuation disconnect - InvestingPro data cited in filings indicates the stock is trading above a calculated Fair Value, reflecting an uncertainty about the market price relative to the cited valuation measure.

More from Insider Trading

Northfield Bancorp Executive Vice President Adds $98,025 in Stock to Holdings Mar 20, 2026 Core Natural Resources SVP Disposes of $1.6M in Shares; Mine Section Temporarily Closed After MSHA Order Mar 20, 2026 NB Bancorp CEO Buys $103,870 in Stock as Company Reports Q4 Results Mar 20, 2026 AirSculpt Insider Jorey Chernett Purchases $205,133 of AIRS Shares; Company Seeks Filing Extension Mar 20, 2026 Director Sells $62,000 of Artesian Resources Stock as Company Confirms Quarterly Dividend Mar 20, 2026